Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

DGIIN: Interactive guidance for COVID-19 therapy options launched

As the corona pandemic progresses, the amount of scientific knowledge, study results and therapy recommendations also increases. Treatment strategies are becoming increasingly more complex and new therapy options are being published more and more frequently. In order to show the treating doctors possible low-threshold options for action for the patient's respective phase of illness, experts have now developed an online tool. The Intensive Care Medicine, Infectious Diseases and Emergency Medicine (COVRIIN) specialist group and the leading specialist societies of the S3 guidelines for inpatient therapy of COVID-19 patients worked on the creation of the tool as part of a joint project, including the German Society for Internal Medicine Intensive Care Medicine and Emergency Medicine eV (DGIIN).

The new interactive tool “COVID-19 therapy recommendations: Interactive guidance for doctors” is based on the recommendations of the current S3 guideline “Recommendations for inpatient therapy of patients with COVID-19” as well as on the practical advice and recommendations for action from the specialist group COVRIIN. The interactive nature of the tool makes it possible to provide practitioners with an individual compilation of the recommended therapy for each patient. The corresponding phase of the disease, the extent of respiratory support, the individual risk factors and the vaccination status of the patient to be treated are taken into account.

Since the beginning of the corona pandemic, the scientific medical societies have already developed various guidelines that summarize the current status of evidence-based medicine in this area. The S3 guideline - “Recommendations for inpatient therapy of patients with COVID-19” was developed by the specialist societies DGIIN, German Interdisciplinary Association for Intensive Care and Emergency Medicine eV (DIVI), German Society for Pneumology and Respiratory Medicine eV (DGP) and Deutsche Society for Infectious Diseases eV (DGI).

In order to strengthen the interdisciplinary advisory capacity on COVID-19 in Germany, the Robert Koch Institute (RKI) launched a national specialist group of clinical infectiologists and intensive care and emergency physicians (“FG COVRIIN”) in May 2020. The aim was, among other things, to develop practical tips for everyday treatment by clinicians for clinicians. Both the leading specialist societies for the S3 guidelines and the members of the COVRIIN specialist group have now developed the online tool together. This is intended to make the recommendations of the guidelines and the working group available to the treating doctors in a tailor-made manner.

The experts who were involved in developing the tool have determined that in practice there is a great need for timely updating and synchronization of relevant information and guidelines. The web-based tool now forms the synthesis of the available knowledge and recommendations for action and is based on a common COVID-19 therapy guide. The tool should also offer the opportunity to comment on the existing recommendations in a timely manner and allow ongoing evaluation and dynamic development of the recommendations.

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.